Eric A. Hughes is See "Remarks" at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA). They have made 4 open-market trades across 1 company since 2023, most recently 2026-08-03.
CIK 0001938678
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TEVA | 134,877 | $5.6M |
Shares reported on the most recent Form 4, priced at the 2026-08-05 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TEVA | SELL · 10b5-1 | 2026-08-03 | 2026-08-05 | $34.88 | $892K | +5.1% | +4.8% | — |
| TEVA | SELL | 2026-03-05 | 2026-03-09 | $31.67 | $302K | -6.2% | -2.7% | +6.0% |
| TEVA | SELL | 2026-03-04 | 2026-03-06 | $32.46 | $366K | -3.0% | -2.3% | +12.7% |
| TEVA | SELL | 2026-03-03 | 2026-03-05 | $32.36 | $2.6M | -3.4% | -4.3% | +5.4% |
| TEVA | SELL · 10b5-1 | 2025-08-01 | 2025-08-05 | $15.16 | $1.6M | +13.4% | +17.3% | +30.3% |
| TEVA | SELL · 10b5-1 | 2025-03-04 | 2025-03-06 | $15.79 | $734K | +7.2% | -9.4% | +13.9% |
| TEVA | SELL · 10b5-1 | 2025-03-03 | 2025-03-05 | $16.06 | $800K | +7.3% | -11.4% | +10.3% |
| TEVA | SELL | 2024-08-09 | 2024-08-13 | $17.38 | $1.6M | +7.9% | +4.7% | +1.0% |
| TEVA | SELL · 10b5-1 | 2024-08-01 | 2024-08-05 | $17.25 | $847K | +8.7% | +12.5% | +10.6% |
| TEVA | SELL · 10b5-1 | 2024-03-04 | 2024-03-05 | $13.34 | $215K | -1.1% | +2.6% | +25.0% |
| TEVA | SELL · 10b5-1 | 2023-08-01 | 2023-08-03 | $8.30 | $876K | -0.4% | -0.1% | -8.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.